Tag Archives: vaccines

Pfizer Inc surpassed analysts’ expectations for first-quarter earnings on Tuesday, thanks to robust demand for recently acquired drugs and pneumococcal vaccinations, which helped offset the impact of falling sales of its COVID-19 medications. The pharmaceutical company is under pressure to spend the windfall profits from strong demand for its COVID …

Moderna’s Q2 results have beaten Wall Street’s quarterly earnings and revenue expectations. The Boston-based company generated $4.7 billion in sales for the quarter, a 9% increase over the same period last year.The biotech company’s costs rose to $1.4 billion, or 30% of the revenue generated from its vaccine. Moderna also …

Pfizer Inc. recorded quarterly profits above analysts’ expectations, and its revenues rose, but less than estimates, while it expects to record strong sales of its vaccine and treatment for the Coronavirus. Pfizer’s fourth-quarter revenue more than doubled overall to $23.84 billion year-over-year, driven by $12.5 billion in sales of its …

Pfizer and Biotech said Tuesday they have started a clinical trial to test a new version of their vaccine specifically designed to target the omicron mutant of COVID-19 that has eluded some of the protection provided by the original two-dose vaccine regimen. The two companies intend to test the immune …

European shares rose on Wednesday, led by gains in food delivery stocks, despite continuing concerns about the prospects for a global recovery in light of the increase in COVID-19 cases due to the spread of the mutant Omicron. The pan-European Stoxx 600 index rose 0.1 percent after it had jumped …

European stocks tracked a global market rebound Tuesday, boosted by hopes that vaccines will work to stem the tide of surging omicron cases. However, a brewing energy crisis appeared to loom with a key Russian pipeline reversing course and raising questions about whether politics were behind the reversal.The Stoxx Europe …

Shares of the COVID-19 vaccine makers Pfizer, Ocugen, and Vaxart are all moving in the negative direction on Monday. Specifically, Pfizer’s stock is down by approximately 4%, Ocugen’s equity is in the red by 5.64%, and Vaxart’s shares are underwater by a hefty 8.7%, as of 12:23 p.m. ET Monday …